169 related articles for article (PubMed ID: 12120411)
21. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs.
Guengerich FP; Hosea NA; Parikh A; Bell-Parikh LC; Johnson WW; Gillam EM; Shimada T
Drug Metab Dispos; 1998 Dec; 26(12):1175-8. PubMed ID: 9860923
[TBL] [Abstract][Full Text] [Related]
22. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
Chen L; Waxman DJ; Chen D; Kufe DW
Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
[TBL] [Abstract][Full Text] [Related]
24. Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome p450 enzymes?
Blobaum AL
Drug Metab Dispos; 2006 Jan; 34(1):1-7. PubMed ID: 16369051
[TBL] [Abstract][Full Text] [Related]
25. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation.
Joo H; Lin Z; Arnold FH
Nature; 1999 Jun; 399(6737):670-3. PubMed ID: 10385118
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450s in the development of target-based anticancer drugs.
Purnapatre K; Khattar SK; Saini KS
Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
[TBL] [Abstract][Full Text] [Related]
27. From electrochemistry to enzyme kinetics of cytochrome P450.
Shumyantseva VV; Kuzikov AV; Masamrekh RA; Bulko TV; Archakov AI
Biosens Bioelectron; 2018 Dec; 121():192-204. PubMed ID: 30218927
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450. Mechanisms of action and clinical implications.
Williams MT
J Fla Med Assoc; 1992 Jun; 79(6):405-8. PubMed ID: 1640215
[TBL] [Abstract][Full Text] [Related]
29. Brief historical overview and recent progress on cytochromes P450: adaptation of aerobic organisms to their chemical environment and new mechanisms of prodrug bioactivation.
Mansuy D
Ann Pharm Fr; 2011 Jan; 69(1):62-9. PubMed ID: 21296219
[TBL] [Abstract][Full Text] [Related]
30. Microbial P450 Enzymes in Bioremediation and Drug Discovery: Emerging Potentials and Challenges.
Bhattacharya SS; Yadav JS
Curr Protein Pept Sci; 2018; 19(1):75-86. PubMed ID: 27875967
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation.
Weaver R; Graham KS; Beattie IG; Riley RJ
Drug Metab Dispos; 2003 Jul; 31(7):955-66. PubMed ID: 12814974
[TBL] [Abstract][Full Text] [Related]
32. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Roy P; Waxman DJ
Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
[TBL] [Abstract][Full Text] [Related]
33. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
Ng SF; Waxman DJ
Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
[TBL] [Abstract][Full Text] [Related]
34. Cytochromes P450: exploiting diversity and enabling application as biocatalysts.
Grogan G
Curr Opin Chem Biol; 2011 Apr; 15(2):241-8. PubMed ID: 21145278
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects on cytochrome p450 enzymes of pentamidine and its amidoxime pro-drug.
Bürenheide A; Kunze T; Clement B
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):61-5. PubMed ID: 18346045
[TBL] [Abstract][Full Text] [Related]
36. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
37. Activation of procarcinogens by human cytochrome P450 enzymes.
Guengerich FP; Shimada T
Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
[TBL] [Abstract][Full Text] [Related]
38. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
39. A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments.
Li Y; Drummond DA; Sawayama AM; Snow CD; Bloom JD; Arnold FH
Nat Biotechnol; 2007 Sep; 25(9):1051-6. PubMed ID: 17721510
[TBL] [Abstract][Full Text] [Related]
40. Carrier protein substrates in cytochrome P450-catalysed oxidation.
Cryle MJ
Metallomics; 2011 Apr; 3(4):323-6. PubMed ID: 21243168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
